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Acetic Acid, the Active Component of Vinegar, Is an Effective
Tuberculocidal Disinfectant
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ABSTRACT Effective and economical mycobactericidal disinfectants are needed to kill both Mycobacterium tuberculosis and
non-M. tuberculosis mycobacteria. We found that acetic acid (vinegar) efficiently kills M. tuberculosis after 30 min of exposure
to a 6% acetic acid solution. The activity is not due to pH alone, and propionic acid also appears to be bactericidal. M. bolletii
and M. massiliense nontuberculous mycobacteria were more resistant, although a 30-min exposure to 10% acetic acid resulted in
at least a 6-log10 reduction of viable bacteria. Acetic acid (vinegar) is an effective mycobactericidal disinfectant that should also
be active against most other bacteria. These findings are consistent with and extend the results of studies performed in the early
and mid-20th century on the disinfectant capacity of organic acids.
IMPORTANCE Mycobacteria are best known for causing tuberculosis and leprosy, but infections with nontuberculous mycobac-
teria are an increasing problem after surgical or cosmetic procedures or in the lungs of cystic fibrosis and immunosuppressed
patients. Killing mycobacteria is important because Mycobacterium tuberculosis strains can be multidrug resistant and therefore
potentially fatal biohazards, and environmental mycobacteria must be thoroughly eliminated from surgical implements and
respiratory equipment. Currently used mycobactericidal disinfectants can be toxic, unstable, and expensive. We fortuitously
found that acetic acid kills mycobacteria and then showed that it is an effective mycobactericidal agent, even against the very
resistant, clinically important Mycobacterium abscessus complex. Vinegar has been used for thousands of years as a common
disinfectant, and if it can kill mycobacteria, the most disinfectant-resistant bacteria, it may prove to be a broadly effective, eco-
nomical biocide with potential usefulness in health care settings and laboratories, especially in resource-poor countries.
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Mycobacteria are important agents of human infections.While the most well-known infections are tuberculosis and
leprosy, infections with nontuberculous mycobacteria are an in-
creasing problem in soft tissues after surgical or cosmetic proce-
dures (1) or in the lungs of cystic fibrosis and immunosuppressed
patients (2). Killing mycobacteria in health care settings is impor-
tant because Mycobacterium tuberculosis strains in clinical speci-
mens or cultures may contain drug-resistant organisms that are
difficult or impossible to eradicate (3), and environmental myco-
bacteria must be thoroughly eliminated from surgical implements
and respiratory equipment.
Disinfection of mycobacteria can be a problem, as mycobacte-
ria are the most disinfectant-resistant bacteria (4). Quaternary
ammonium compound (QAC) disinfectants are regarded as only
mycobacteriostatic (4), and QAC tolerance is a problem with my-
cobacteria of the Mycobacterium abscessus complex (5). Some of
the more effective disinfectants (6), such as chlorine bleach and
peracetic acid, can be relatively toxic, unstable, or expensive (4),
and the emergence of glutaraldehyde-resistant strains has caused
extensive outbreaks of nontuberculosis infections (7).
While using acetic acid as a solvent, we fortuitously found that
it had significant mycobactericidal activity. Vinegar has been used
as a disinfectant for thousands of years (8, 9) and is today com-
monly used for, among other things, eliminating bacteria from
fresh produce (10, 11) or curing acute otitis externa (12, 13).
There is a description of its use in the Middle Ages for treating
infected wounds and scrofula, which generally means tuberculosis
of the lymph nodes in the neck (http://en.wikipedia.org/wiki
/Medieval_medicine_of_Western_Europe). In this study, we
quantitated the significant mycobactericidal activity of acetic acid
and suggest that it may be a useful, low-cost, and effective disin-
fectant.
Acetic acid or vinegar was added to aliquots of bacterial cul-
tures in proportions to create the concentrations shown in Ta-
ble 1. Commercial white vinegar was used whenever possible. The
cultures were then inverted several times and incubated at room
temperature without agitation for the specified periods (20 to
30 min). They were then centrifuged, and the pellet was resus-
pended in Middlebrook 7H9 medium supplemented with oleic
acid-albumin-dextrose-catalase (OADC). Aliquots of serial dilu-
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tions were plated on LB agar plates for Escherichia coli and Middle-
brook 7H10 plates for mycobacteria, except for Mycobacterium
smegmatis, which was plated on either medium with the same
results. All experiments were performed at least twice, and the
results were the same whether the bacterial pellets were resus-
pended in Middlebrook 7H9 medium-OADC or in a sodium hy-
droxide solution to neutralize the acetic acid. Negative controls
with sterile water were included to determine the original number
of viable bacteria.
Exposure to acetic acid at a concentration of 5% for 20 min
reduced viable Escherichia coli DH5 and M. smegmatis mc2155
bacteria by at least 7 log10 (Table 1). In some experiments in which
the initial culture had ~9 log10 of bacteria/ml, there were rare
surviving colonies of E. coli and M. smegmatis. When these colo-
nies were grown in broth media and tested again, they showed no
evidence of resistance or tolerance to acetic acid, and their expo-
sure to 5% for 20 min again produced 7 log10 of killing.
To test whether the low pH of acetic acid was responsible for
the bactericidal effect, we exposed M. smegmatis and E. coli for
20 min to a dilute solution of HCl in water with pH 2.5, corre-
sponding approximately to the pH of 5% acetic acid. No bacteri-
cidal effect was seen (data not shown). Other studies have looked
at the effect of pH on mycobacterial growth by reducing the pH in
the culture media to as low as pH 3 with HCl or pH 5 with citric
acid and found that after a couple of days, the number of viable
bacteria was reduced by only approximately 1 log10 (14, 15).
Next, to determine whether the effect was specific for acetic
acid, a two-carbon acid, we also tested solutions of the three-
carbon propionic acid that had been diluted to have approxi-
mately the same molarity as 6% acetic acid. Propionic acid had
bactericidal activity against both E. coli (Table 1) and M. abscessus.
A 13.7% solution of sodium acetate, with about the same molarity
as 10% acetic acid, produced less than a 1-log(10) killing of
M. smegmatis (data not shown), indicating that the bactericidal
effect of acetic acid was caused by its carboxylic acid function.
We then tested for activity against M. tuberculosis. While expo-
sure to 5% acetic acid for 20 min obtained only a 3- to 4-log10
reduction of viable bacteria, exposure to a 6% solution for 30 min
resulted in at least an 8-log10 reduction. The same levels of myco-
bactericidal activity were seen with virulent (H37Rv) and aviru-
lent auxotrophic (mc27000 [H37Rv RD1 panCD]) (16) M. tu-
berculosis laboratory strains, as well as with multidrug-resistant
(MDR) and extensively drug-resistant (XDR) M. tuberculosis clin-
ical isolates.
We also tested acetic acid on the notoriously resistant Myco-
bacterium abscessus complex bacteria (17). Although M. abscessus
sensu stricto was efficiently killed by exposure to 6% acetic acid for
30 min, Mycobacterium bolletii and Mycobacterium massiliense
were more resistant. The levels of reduction in viable bacteria dif-
fered somewhat in different experiments, but exposure to 10%
acetic acid for 30 min achieved a minimum of a 6-log10 reduction
in the colony counts of these two species, with M. massiliense
appearing to be slightly more resistant than M. bolletii.
Finally, we demonstrated that the mycobactericidal activity re-
mained even under “dirty” conditions that were meant to simu-
late contamination with organic material in clinical samples, with
the acetic acid solution containing 2 to 3.5% bovine serum albu-
min and 2 to 3.5% red blood cells (Table 1).
The results described above suggest that acetic acid can be an
effective, economical bactericidal agent for M. tuberculosis and
TABLE 1 Bactericidal effect of increasing exposure times and acid concentrations
Acid and/or
conditions
Solution characteristicsa Log10 reduction of viable bacteria
b
BSA
and
RBC
concn
(%)c pH
pH with
M.
abscessusd
Molar
concn
Exposure
time
(min)
Final
concn
(%)
E. coli
DH5
E. coli
survivors
M.
smegmatis
M.
smegmatis
survivors
M.
tuberculosis
mc27000
M.
tuberculosis
H37Rv
MDR
M.
tuberculosis
XDR
M.
tuberculosis
M.
abscessus
M.
bolletii
M.
massiliense
Rf
M.
massiliense
S.f
Acetic acid 0.34 20 2.5 3 2
0.40 30 3 4 4 3
0.54 20 4 3 4 3 3
2.45 2.62 0.83 20 5 8.5 7 7 7 3 4.5 3 4
0.83 25 5 5
0.83 30 5 7e 5
2.43 2.57 1.00 25 6 9e 5.5 4 2
1.00 30 6 8e 7e 8e 8e 8e 8 5 3 3
2.31 2.42 1.33 30 8 8e 8e 8e 7 4.5 5
2.27 2.40 1.67 30 10 8e 8e 8e 8e 6 6 6
Acetic acid,
dirty conditions 2 20 6 6
3 25 6 7
3.5 25 7 9e
2.5 30 10 8e
Propionic
acid 0.9 20 6.7 8e
1.08 20 8.0 7
1.08 25 8.0 7
1.15 20 8.5 8e
a High-level disinfectant activity is indicated in bold.
b The numbers represent the reductions, expressed in log10, in the number of colonies recovered after the acid exposures, compared to that of controls exposed to sterile water alone
under the same conditions.
c BSA, bovine serum albumin; RBCs, human red blood cells.
d M. abscessus with optical density at 600 nm of 1 was diluted 1:10 in the acetic acid solutions.
e Limit of detection (no colonies recovered from exposed bacteria).
f R and S refer to the rough and smooth morphotypes of M. massiliense.
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nontuberculous mycobacteria, although the 20- to 30-min expo-
sure time required to obtain optimal killing is longer than the
5 min recommended for some commercial bactericides. Exposure
to 6% acetic acid for 30 min resulted in an 8-log10 reduction of
viable M. tuberculosis bacteria, including XDR and MDR strains.
In tests with the M. abscessus complex, which are emerging as the
most pathogenic of the nontuberculous mycobacteria (17), the
same conditions produced 8 log10 of killing only with M. abscessus
sensu stricto, while M. massiliense and M. bolletii were more resis-
tant in some assays. However, the generally accepted definition of
an effective mycobactericide is one that has the ability to reduce
viable bacteria by 4 to 5 log10 (18), while the 6-log10 reduction of
both these bacteria achieved with 10% acetic acid for 30 min
would be classified as high-level mycobactericidal activity (19). In
some assays in which 109 M. smegmatis bacteria were exposed to
6% acetic acid for 20 min and 3  109 M. massiliense bacteria were
exposed to 10% acetic acid for 30 min, there were no survivors.
Although we did not attempt carrier tests, the effective mycobac-
tericidal activity was maintained even under “dirty” conditions
that simulate contamination with organic material. While this
level of killing may not be adequate for all critical uses, such as
sterilizing surgical instruments, it is likely that higher levels of
killing of these highly resistant strains could be achieved with
higher concentrations of acetic acid and/or longer exposure times
than the ones tested here. Preliminary studies, however, suggest
that 10% acetic acid for 30 min does not kill Bacillus subtilis spores
(data not shown), so it cannot be classified as a high-level general
disinfectant (20). We have not assessed the activity of acetic acid
against viruses and fungi.
Although the disinfectant properties of organic acids such as
acetic acid, propionic acid, and butyric acid—a component of
sweat (21)—are well known, they are not usually included in re-
views of bactericides (4). However, in the early part of the 20th
century, they were fairly extensively studied for disinfectant prop-
erties, as reviewed by Reid in 1932 (22), and their tuberculocidal
activity was evaluated by Barker in 1964 (23). It was found that
they had broad bactericidal activity that increased with increasing
carbon chain length through caprylic acid (C  8), although the
longer-chain acids were less soluble. Bactericidal activity was also
found to increase with decreasing surface tension of the organic
acid solutions and appeared to be due to the undissociated acid
rather than the hydrogen ion concentration. It was therefore sug-
gested that the bactericidal effect might be related to the ability of
the acids to pass through the bacterial membrane (23).
Acetic acid is not very toxic, although prolonged exposure will
produce corrosive effects, both on skin and metals. In reports
from nearly 100 years ago, it was found that the topical application
of a 1% acetic acid solution in saline cured Pseudomonas aerugi-
nosa (Bacillus pyocyaneus) wound infections (24, 25). It might be
worthwhile testing its effectiveness as a topical agent on mycobac-
terial ulcers (26, 27).
Acetic acid is relatively inexpensive—2.5 liters of 99% acetic
acid costs less than US$100 and could effectively disinfect up to
20 liters of M. tuberculosis cultures or sputa. Commercial vinegar
bought in supermarkets was used wherever possible in the exper-
iments described here, but the concentrations vary from country
to country. Commercial vinegar could be used at effective concen-
trations for M. smegmatis or M. tuberculosis in France, where it is
sold as 8% acetic acid, but not in the United States or Venezuela,
where vinegar is sold as 5% acetic acid. While longer-chain or-
ganic acids may have better bactericidal activity, acetic acid (vin-
egar) is relatively nontoxic, inexpensive, and available, which
could make it an effective, economical biocide for disinfecting
M. tuberculosis from clinical specimens, cultures, and laboratory
surfaces, and it would be particularly useful in low-income coun-
tries. The high-level capacity of acetic acid in killing mycobacteria,
regarded as the most disinfectant-resistant bacteria due to the
structure of their lipid-rich cell walls (4), suggests that perhaps it
should be revived as a broadly effective bactericide that can be
used as a general sanitizer.
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